http://www.huliq.com/tags/chronic-hepatitis-c The taxonomy view with a depth of 0. en http://www.huliq.com/52439/serum-fibrosis-markers-correlate-liver-fibrosis-stage-patients-hepatitis-c A prospective study of patients with advanced <strong>chronic hepatitis C</strong> (CHC) revealed that a 3-variable model of serum fibrosis markers, including serum HA, TIMP-1 and platelet count, could identify <strong>cirrhosis</strong> with better accuracy than other published models. http://www.huliq.com/52439/serum-fibrosis-markers-correlate-liver-fibrosis-stage-patients-hepatitis-c#comments Health chronic hepatitis C cirrhosis cirrhosis treatment fibrosis liver fibrosis Mon, 03 Mar 2008 13:20:00 -0600 harminka 52439 at http://www.huliq.com http://www.huliq.com/48709/regular-marijuana-use-increases-risk-hepatitis-crelated-liver-damage Patients with <strong>chronic hepatitis C</strong> (HCV) infection should not use marijuana (cannabis) daily, according to a study published in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. http://www.huliq.com/48709/regular-marijuana-use-increases-risk-hepatitis-crelated-liver-damage#comments Health chronic hepatitis C hepatitis C infection hepatitis C infection treatment marijuana use Tue, 29 Jan 2008 09:49:41 -0600 harminka 48709 at http://www.huliq.com http://www.huliq.com/41409/interferon-does-not-slow-or-stop-hepatitis-c-from-worsening Interferon does not slow or halt the progression of <strong>chronic hepatitis C</strong> and advanced liver disease in patients who haven’t responded to previous attempts to eradicate the disease, a national study in which the Saint Louis University School of Medicine participated has found. http://www.huliq.com/41409/interferon-does-not-slow-or-stop-hepatitis-c-from-worsening#comments Health chronic hepatitis C hepatitis C infection treatment liver disease Sun, 11 Nov 2007 14:56:54 -0600 harminka 41409 at http://www.huliq.com http://www.huliq.com/40760/positive-results-from-phase-2b-trial-of-albuferon-for-hepatits-c Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced the final quality-of-life results from a Phase 2b clinical trial of the investigational drug, Albuferon® (albinterferon alfa-2b), in combination with ribavirin in treatment-naive patients with genotype 1 <strong>chronic hepatitis C</strong>. http://www.huliq.com/40760/positive-results-from-phase-2b-trial-of-albuferon-for-hepatits-c#comments Health chronic hepatitis C hepatitis C infection treatment Tue, 06 Nov 2007 07:20:28 -0600 harminka 40760 at http://www.huliq.com http://www.huliq.com/40665/results-of-phase-2b-trial-of-albuferon-for-chronic-hepatitis-c Human Genome Sciences, Inc. (NASDAQ: HGSI) today announced the final results of a Phase 2b clinical trial of the investigational drug, Albuferon® (albinterferon alfa-2b), in combination with ribavirin in treatment-naive patients with genotype 1 <strong>chronic hepatitis C</strong>. http://www.huliq.com/40665/results-of-phase-2b-trial-of-albuferon-for-chronic-hepatitis-c#comments Health chronic hepatitis C clinical trials hepatitis C treatment Mon, 05 Nov 2007 12:21:15 -0600 harminka 40665 at http://www.huliq.com http://www.huliq.com/4539/interferon-treated-hepatitis-c-patients-likely-to-experience-retinopathy http://www.huliq.com/4539/interferon-treated-hepatitis-c-patients-likely-to-experience-retinopathy#comments Health chronic hepatitis C Hepatology Interferon Ophthalmology retinopathy treatments Wed, 03 Jan 2007 12:45:59 -0600 harminka 4539 at http://www.huliq.com